Funding
Funding
NEWS
Welcome aboard to Tsai-Tzu, Yu-Han, and Tzu-Ching, who joined our group this September!
A huge welcome to our new Research Assistant, Tsai-Tzu, and Master’s students, Yu-Han and Tzu-Ching! They will be tackling challenging uronic acid oligosaccharides to uncover how sugar conformation influences pancreatic cancer. Excited to have you on the carbohydrate chemistry team!.
Sep 28, 2026
Congratulations to Dr. Chang on publishing new work in JACS!
The study, titled "Stereoselectivity of Galactosylation Reactions in Vacuo", utilizes gas-phase reaction systems to probe pure SN1 mechanism in carbohydrate synthesis. This work offers fresh mechanistic insights into short-lived reaction intermediates, marking a key advancement in carbohydrate chemistry. Link
Aug 20, 2026
Welcome Bing-Nuo Lee, joining our group as a research assistant!
Bing-Nuo is a chemist by training and graduated from National Taiwan University. His research focuses on transition-state calculations in organic reactions. He will now expand his interests to more complex enzyme systems and explore how the structure of biomolecules influences catalytic efficiency.
Jul 30, 2026
Institute of Chemistry, Academia Sinica Startup Grant (2026-2027)
Snapshots of the Reactive Sugar Intermediates: From Enzymes to Chemistry
Carbohydrate synthesis remains a formidable challenge due to the unpredictable behavior of glycosylium ion intermediates, which often leads to unreliable stereochemical outcomes. This project addresses the long-standing "1,2-cis linkage" problem by employing an enzyme-inspired (biomimetic) strategy. By using phosphate sugar analogues activated by metal catalysts, we replicate the key interactions found within enzyme active sites. This approach allows us to stabilize and study reactive intermediates in a simplified, biologically relevant environment. Our goal is to map these structural parameters to provide a predictive, step-by-step framework for glycosidic bond formation. Establishing this bottom-up strategy will not only advance fundamental glycobiology but also streamline the development of glycan-based vaccines and targeted enzyme inhibitors.